China Universal Asset Management Company’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $807K | Buy |
12,778
+96
| +0.8% | +$6.07K | 0.08% | 191 |
|
|
2025
Q1 | $672K | Sell |
12,682
-349
| -3% | -$18.5K | 0.06% | 216 |
|
|
2024
Q4 | $729K | Buy |
13,031
+1,273
| +11% | +$71.3K | 0.07% | 204 |
|
|
2024
Q3 | $616K | Buy |
11,758
+4,595
| +64% | +$241K | 0.07% | 193 |
|
|
2024
Q2 | $294K | Sell |
7,163
-4,398
| -38% | -$181K | 0.04% | 194 |
|
|
2024
Q1 | $501K | Buy |
11,561
+4,724
| +69% | +$205K | 0.06% | 180 |
|
|
2023
Q4 | $314K | Buy |
6,837
+5,379
| +369% | +$247K | 0.06% | 171 |
|
|
2023
Q3 | $33.4K | Buy |
1,458
+713
| +96% | +$16.3K | 0.01% | 259 |
|
|
2023
Q2 | $12.3K | Sell |
745
-18
| -2% | -$297 | ﹤0.01% | 307 |
|
|
2023
Q1 | $13.6K | Buy |
763
+191
| +33% | +$3.41K | ﹤0.01% | 257 |
|
|
2022
Q4 | $16.7K | Buy |
572
+97
| +20% | +$2.83K | 0.01% | 186 |
|
|
2022
Q3 | $12K | Buy |
+475
| New | +$12K | 0.01% | 188 |
|